Candel Therapeutics IncNASDAQ:CADL
- LAST PRICE8.9000
- TODAY'S CHANGE (%)0.2800 (3.2483%)
- Bid / Lots8.9800/ 4
- Ask / Lots9.0300/ 1
- Open / Previous Close8.8600 / 8.6200
- Day Range
- 52 Week Range
- Volume630,203
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CADL |
|---|---|---|
| 09:32 ET | 5234 | 8.6518 |
| 09:34 ET | 3239 | 8.7262 |
| 09:36 ET | 300 | 8.81 |
| 09:38 ET | 15876 | 8.99 |
| 09:39 ET | 11893 | 8.9002 |
| 09:41 ET | 11697 | 8.945 |
| 09:43 ET | 8591 | 9 |
| 09:45 ET | 300 | 8.96 |
| 09:48 ET | 100 | 8.95 |
| 09:50 ET | 1000 | 8.92 |
| 09:52 ET | 1849 | 8.86 |
| 09:54 ET | 4009 | 8.9 |
| 09:56 ET | 4205 | 8.8512 |
| 09:57 ET | 900 | 8.86 |
| 09:59 ET | 784 | 8.8554 |
| 10:01 ET | 2028 | 8.84 |
| 10:03 ET | 3740 | 8.78 |
| 10:06 ET | 14675 | 8.8948 |
| 10:08 ET | 3817 | 9 |
| 10:10 ET | 7231 | 9.02 |
| 10:12 ET | 1150 | 9.0001 |
| 10:14 ET | 4089 | 9.0032 |
| 10:15 ET | 10476 | 9.025 |
| 10:17 ET | 18225 | 9.075 |
| 10:19 ET | 5058 | 9.12 |
| 10:21 ET | 8869 | 9.235 |
| 10:24 ET | 15481 | 9.18 |
| 10:26 ET | 18278 | 9.12 |
| 10:28 ET | 9047 | 9.15 |
| 10:30 ET | 4544 | 9.19 |
| 10:32 ET | 3471 | 9.2 |
| 10:33 ET | 4250 | 9.2 |
| 10:35 ET | 5612 | 9.13 |
| 10:37 ET | 5130 | 9.0326 |
| 10:39 ET | 2841 | 9.01 |
| 10:42 ET | 2289 | 9.11 |
| 10:44 ET | 417 | 9.07 |
| 10:46 ET | 2500 | 8.99 |
| 10:48 ET | 7300 | 8.955 |
| 10:50 ET | 30180 | 8.87 |
| 10:51 ET | 300 | 8.85 |
| 10:53 ET | 1700 | 8.77 |
| 10:55 ET | 13083 | 8.71 |
| 10:57 ET | 1697 | 8.7546 |
| 11:00 ET | 2483 | 8.75 |
| 11:02 ET | 5840 | 8.76 |
| 11:04 ET | 1930 | 8.7427 |
| 11:08 ET | 2760 | 8.743 |
| 11:09 ET | 1315 | 8.71 |
| 11:11 ET | 500 | 8.7377 |
| 11:13 ET | 311 | 8.75 |
| 11:15 ET | 500 | 8.74 |
| 11:18 ET | 4727 | 8.725 |
| 11:20 ET | 1281 | 8.7393 |
| 11:22 ET | 1500 | 8.75 |
| 11:24 ET | 500 | 8.73 |
| 11:26 ET | 214 | 8.79 |
| 11:27 ET | 1000 | 8.75 |
| 11:31 ET | 600 | 8.745 |
| 11:33 ET | 700 | 8.74 |
| 11:36 ET | 3517 | 8.79 |
| 11:40 ET | 2564 | 8.735 |
| 11:42 ET | 5643 | 8.653 |
| 11:44 ET | 2784 | 8.65 |
| 11:45 ET | 2606 | 8.662 |
| 11:47 ET | 1322 | 8.68 |
| 11:49 ET | 100 | 8.65 |
| 11:51 ET | 4897 | 8.76 |
| 11:54 ET | 450 | 8.75 |
| 11:56 ET | 571 | 8.775 |
| 11:58 ET | 600 | 8.754 |
| 12:00 ET | 4225 | 8.785 |
| 12:02 ET | 4200 | 8.76 |
| 12:03 ET | 500 | 8.7468 |
| 12:05 ET | 600 | 8.78 |
| 12:07 ET | 681 | 8.76 |
| 12:09 ET | 700 | 8.8 |
| 12:12 ET | 100 | 8.785 |
| 12:14 ET | 481 | 8.7298 |
| 12:16 ET | 1180 | 8.7995 |
| 12:18 ET | 1000 | 8.7999 |
| 12:20 ET | 992 | 8.8 |
| 12:23 ET | 400 | 8.7546 |
| 12:25 ET | 4833 | 8.77 |
| 12:27 ET | 700 | 8.765 |
| 12:32 ET | 747 | 8.75 |
| 12:34 ET | 650 | 8.7696 |
| 12:36 ET | 1237 | 8.79 |
| 12:38 ET | 100 | 8.8 |
| 12:43 ET | 500 | 8.7351 |
| 12:48 ET | 650 | 8.79 |
| 12:50 ET | 3602 | 8.78 |
| 12:57 ET | 2460 | 8.75 |
| 12:59 ET | 200 | 8.77 |
| 01:01 ET | 1200 | 8.79 |
| 01:03 ET | 100 | 8.77 |
| 01:06 ET | 2196 | 8.84 |
| 01:14 ET | 2800 | 8.87 |
| 01:15 ET | 4402 | 8.8632 |
| 01:17 ET | 3847 | 8.95 |
| 01:19 ET | 3200 | 8.9787 |
| 01:21 ET | 100 | 8.975 |
| 01:24 ET | 760 | 8.92 |
| 01:26 ET | 500 | 8.9664 |
| 01:28 ET | 265 | 8.93 |
| 01:30 ET | 869 | 8.92 |
| 01:32 ET | 500 | 8.9206 |
| 01:33 ET | 414 | 8.9201 |
| 01:35 ET | 350 | 8.92 |
| 01:39 ET | 150 | 8.9 |
| 01:42 ET | 224 | 8.9433 |
| 01:44 ET | 6915 | 9 |
| 01:48 ET | 500 | 8.99 |
| 01:50 ET | 1600 | 9 |
| 01:51 ET | 100 | 9 |
| 01:53 ET | 100 | 9 |
| 01:55 ET | 1500 | 8.985 |
| 01:57 ET | 4800 | 8.97 |
| 02:04 ET | 300 | 8.9 |
| 02:06 ET | 400 | 8.91 |
| 02:08 ET | 600 | 8.945 |
| 02:09 ET | 8735 | 8.99 |
| 02:11 ET | 300 | 8.98 |
| 02:13 ET | 8103 | 9.03 |
| 02:15 ET | 2994 | 9.0165 |
| 02:18 ET | 2650 | 8.97 |
| 02:24 ET | 223 | 8.96 |
| 02:26 ET | 17360 | 8.98 |
| 02:27 ET | 800 | 8.96 |
| 02:29 ET | 1162 | 8.9613 |
| 02:33 ET | 10335 | 8.9795 |
| 02:36 ET | 471 | 8.9 |
| 02:38 ET | 200 | 8.94 |
| 02:40 ET | 1069 | 8.96 |
| 02:42 ET | 380 | 8.9765 |
| 02:45 ET | 2828 | 8.9899 |
| 02:47 ET | 12573 | 8.97 |
| 02:49 ET | 3721 | 8.87 |
| 02:51 ET | 5100 | 8.92 |
| 02:56 ET | 550 | 8.85 |
| 03:00 ET | 3816 | 8.8 |
| 03:02 ET | 1350 | 8.805 |
| 03:03 ET | 192 | 8.825 |
| 03:09 ET | 1595 | 8.89 |
| 03:12 ET | 400 | 8.88 |
| 03:14 ET | 400 | 8.87 |
| 03:16 ET | 100 | 8.835 |
| 03:20 ET | 569 | 8.8 |
| 03:23 ET | 1477 | 8.77 |
| 03:25 ET | 1519 | 8.765 |
| 03:27 ET | 500 | 8.76 |
| 03:30 ET | 100 | 8.765 |
| 03:32 ET | 2520 | 8.795 |
| 03:34 ET | 100 | 8.79 |
| 03:36 ET | 300 | 8.795 |
| 03:38 ET | 527 | 8.77 |
| 03:41 ET | 3649 | 8.805 |
| 03:43 ET | 1365 | 8.78 |
| 03:45 ET | 2239 | 8.72 |
| 03:48 ET | 3529 | 8.77 |
| 03:50 ET | 2216 | 8.785 |
| 03:52 ET | 799 | 8.8199 |
| 03:54 ET | 464 | 8.82 |
| 03:56 ET | 1192 | 8.84 |
| 03:57 ET | 646 | 8.835 |
| 03:59 ET | 11381 | 8.9 |
May 30, 2024
DJ Candel Therapeutics Gets FDA's Orphan-Drug Status for Glioma Treatment, from 8:30AM ET on Thursday May 30, 2024 by Dow Jones
8:30AM ET on Thursday May 30, 2024 by Dow JonesFDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma, from 8:00AM ET on Thursday May 30, 2024 by Dow Jones
8:00AM ET on Thursday May 30, 2024 by Dow Jones
May 23, 2024
DJ Candel Therapeutics Shares Pop 39% After Lung-Cancer Treatment Yields Higher Survival in Trial, from 7:16PM ET on Thursday May 23, 2024 by Dow Jones
7:16PM ET on Thursday May 23, 2024 by Dow JonesCandel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting, from 5:00PM ET on Thursday May 23, 2024 by Dow Jones
5:00PM ET on Thursday May 23, 2024 by Dow Jones
May 22, 2024
Candel Therapeutics to Present at the Jefferies Global Healthcare Conference, from 8:00AM ET on Wednesday May 22, 2024 by Dow Jones
8:00AM ET on Wednesday May 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Candel Therapeutics Inc | 264.7M | -6.9x | --- |
ATAI Life Sciences NV | 262.8M | -6.5x | --- |
Black Diamond Therapeutics Inc | 268.9M | -2.8x | --- |
Inovio Pharmaceuticals Inc | 262.5M | -1.8x | --- |
Rani Therapeutics Holdings Inc | 277.3M | -4.3x | --- |
Monte Rosa Therapeutics Inc | 250.7M | -1.6x | --- |
Company Information
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Contact Information
- Headquarters
- 117 Kendrick Street,, Suite 450NEEDHAM, MA, United States 02494
- Phone
- 617-916-5445
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Manning
- President, Chief Executive Officer, Director
- Paul Tak
- Interim Chief Financial Officer
- Charles Schoch
- Chief Scientific Officer
- Francesca Barone
- Vice President - Development Leader
- Christopher Matheny
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $264.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.29 |
Book Value | $0.44 |
P/E Ratio | -6.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
